V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210030504 | 210010386 | 1.82 | 97 | Palliative (P) | 2015-01-11 | 2015-01-26 | Temozolomide + RT | 02 | Y | 210022224 | TEMOZOLOMIDE + RT |
| 210030505 | 210010388 | 1.63 | 90 | Disease modification (D) | null | 2017-10-27 | Temozolomide + RT | N | N | 210022230 | TEMOZOLOMIDE + RT |
| 210030506 | 210020719 | null | 150 | Curative (C) | 2019-01-27 | 2019-02-12 | Temozolomide + RT | null | Y | 210022299 | TEMOZOLOMIDE + RT |
| 210030507 | 210010403 | null | 67.6 | Adjuvant (A) | null | 2015-04-12 | Temozolomide + RT | N | null | 210022448 | TEMOZOLOMIDE + RT |
| 210030508 | 210020732 | null | null | Disease modification (D) | 2015-12-16 | 2015-12-30 | Temozolomide + RT | N | Y | 210022614 | TEMOZOLOMIDE + RT |
| 210030509 | 210010418 | null | 94.9 | Unknown (U) | null | 2017-02-15 | Temozolomide + RT | null | N | 210022620 | TEMOZOLOMIDE + RT |
| 210030510 | 210030960 | 1.87 | null | Curative (C) | 2019-03-07 | 2019-03-07 | Trial Unspecified | N | N | 210022624 | TRIAL |
| 210030511 | 210010428 | 1.61 | 73.8 | Curative (C) | 2019-07-22 | 2019-08-05 | Trial Unspecified | Y | null | 210022728 | TRIAL |
| 210030512 | 210010444 | null | 49.6 | Curative (C) | 2015-07-19 | 2015-07-19 | Trial Unspecified | Y | N | 210022961 | TRIAL |
| 210030513 | 210010446 | 1.29 | 96.3 | null | 2014-07-16 | 2014-08-23 | Temozolomide + RT | N | null | 210022962 | TEMOZOLOMIDE + RT |
| 210030514 | 210010449 | 1.82 | 67.05 | Palliative (P) | null | 2017-11-03 | Temozolomide + RT | N | N | 210023044 | TEMOZOLOMIDE + RT |
| 210030515 | 210020761 | null | 79.8 | Adjuvant (A) | 2016-10-29 | 2016-10-30 | Trial Unspecified | N | null | 210023048 | TRIAL |
| 210030516 | 210010455 | 1.7 | 72.6 | Curative (C) | 2017-06-07 | 2017-07-14 | Trial Unspecified | 01 | Y | 210023081 | TRIAL |
| 210030517 | 210010462 | 1.6 | 83.1 | Curative (C) | 2015-11-20 | 2016-03-25 | CNS HGG HERBY Bevacizumab | Y | null | 210023222 | TRIAL |
| 210030518 | 210020775 | 1.65 | 82 | Curative (C) | 2015-04-13 | 2015-06-07 | Trial Unspecified | N | N | 210023251 | TRIAL |
| 210030519 | 210027162 | 1.67 | 80 | Palliative (P) | 2018-01-13 | 2018-03-16 | Temozolomide + RT | N | null | 210023274 | TEMOZOLOMIDE + RT |
| 210030520 | 210010481 | 0 | 76 | Curative (C) | 2018-09-02 | 2018-09-17 | Temozolomide + RT | N | Y | 210023331 | TEMOZOLOMIDE + RT |
| 210030521 | 210010484 | 1.69 | 67.2 | Curative (C) | 2018-02-04 | 2018-02-24 | Temozolomide + RT | 02 | Y | 210023346 | TEMOZOLOMIDE + RT |
| 210030522 | 210010492 | 1.7 | 76.2 | null | 2017-10-02 | 2017-10-30 | Temozolomide + RT | N | Y | 210023423 | TEMOZOLOMIDE + RT |
| 210030523 | 210010496 | 1.8 | null | Curative (C) | null | 2015-07-14 | Trial Unspecified | N | N | 210023453 | TRIAL |
| 210030524 | 210010498 | 0 | 91.2 | Adjuvant (A) | 2015-01-07 | 2015-01-25 | Trial Unspecified | 01 | N | 210023473 | TRIAL |
| 210030525 | 210010520 | 1.7 | 72.9 | Palliative (P) | null | 2014-02-13 | Trial Unspecified | 01 | N | 210023722 | TRIAL |
| 210030526 | 210034954 | 1.88 | 67.2 | Adjuvant (A) | 2018-11-16 | 2019-01-01 | Temozolomide + RT | N | Y | 210023729 | TEMOZOLOMIDE + RT |
| 210030527 | 210027178 | 1.8 | null | Curative (C) | 2018-05-01 | 2018-07-10 | Temozolomide + RT | N | Y | 210023738 | TEMOZOLOMIDE + RT |
| 210030528 | 210010525 | 1.62 | 15.7 | Adjuvant (A) | 2014-11-25 | 2014-11-25 | Trial Unspecified | 01 | null | 210023790 | TRIAL |
| 210030529 | 210010528 | null | null | Unknown (U) | 2016-02-05 | 2016-02-15 | Trial Unspecified | null | N | 210023841 | TRIAL |
| 210030530 | 210010531 | null | 41 | Curative (C) | 2016-12-27 | 2017-01-14 | Temozolomide + RT | null | Y | 210023859 | TEMOZOLOMIDE + RT |
| 210030531 | 210010531 | 1.89 | 85 | Curative (C) | 2016-12-19 | 2018-10-21 | Trial Unspecified | N | Y | 210023859 | TRIAL |
| 210030532 | 210010535 | 1.69 | 78 | Palliative (P) | 2015-11-10 | 2015-12-10 | Temozolomide + RT | N | N | 210023922 | TEMOZOLOMIDE + RT |
| 210030533 | 210010539 | null | 65.4 | Curative (C) | 2016-10-10 | 2016-12-13 | Temozolomide + RT | N | Y | 210023954 | TEMOZOLOMIDE + RT |
| 210030534 | 210010539 | 1.58 | 84.1 | Curative (C) | 2015-10-19 | 2015-11-04 | ESPHALL TRIAL | N | null | 210023954 | TRIAL |
| 210030535 | 210020831 | null | 65.4 | Curative (C) | null | 2019-09-17 | Temozolomide + RT | N | null | 210023998 | TEMOZOLOMIDE + RT |
| 210030536 | 210010546 | 1.62 | 90 | null | null | 2016-05-30 | Temozolomide + RT | N | Y | 210024052 | TEMOZOLOMIDE + RT |
| 210030537 | 210020836 | 1.5 | 73 | Curative (C) | 2017-03-05 | 2017-03-20 | Temozolomide + RT | N | Y | 210024080 | TEMOZOLOMIDE + RT |
| 210030538 | 210010568 | 1.6 | null | Curative (C) | 2019-04-16 | 2019-05-14 | Temozolomide + RT | N | Y | 210024283 | TEMOZOLOMIDE + RT |
| 210030539 | 210010574 | 1.87 | null | Curative (C) | 2017-03-07 | 2017-03-07 | Trial Unspecified | N | Y | 210024338 | TRIAL |
| 210030540 | 210010577 | 1.63 | 73.3 | Curative (C) | null | 2018-12-15 | Temozolomide + RT | 2 | Y | 210024422 | TEMOZOLOMIDE + RT |
| 210030541 | 210010587 | 1.64 | null | Curative (C) | 2013-11-14 | 2014-11-04 | ESPHALL TRIAL | N | N | 210024534 | TRIAL |
| 210030542 | 210010591 | 1.64 | 52.7 | Disease modification (D) | null | 2017-03-05 | Temozolomide + RT | N | null | 210024563 | TEMOZOLOMIDE + RT |
| 210030543 | 210020873 | 1.57 | 104.5 | Curative (C) | null | 2015-11-22 | Temozolomide + RT | Y | null | 210024579 | TEMOZOLOMIDE + RT |
| 210030545 | 210010608 | 0 | 91.9 | Curative (C) | 2014-12-11 | 2015-04-29 | Trial Unspecified | 01 | N | 210024774 | TRIAL |
| 210030546 | 210010613 | 1.7 | 48 | Curative (C) | 2017-02-26 | 2017-05-10 | Temozolomide + RT | 02 | N | 210024800 | TEMOZOLOMIDE + RT |
| 210030547 | 210010615 | 1.61 | 53.4 | Palliative (P) | 2015-07-09 | 2015-07-16 | ESPHALL TRIAL | 1 | null | 210024818 | TRIAL |
| 210030548 | 210027216 | 1.55 | 76 | Curative (C) | 2015-06-15 | 2015-07-16 | Temozolomide + RT | N | null | 210024926 | TEMOZOLOMIDE + RT |
| 210030549 | 210020895 | 1.7 | null | Curative (C) | 2015-12-14 | 2016-02-18 | Temozolomide + RT | N | N | 210024977 | TEMOZOLOMIDE + RT |
| 210030550 | 210010629 | 1.76 | 85 | Curative (C) | 2017-12-24 | 2018-01-07 | Temozolomide + RT | N | Y | 210025003 | TEMOZOLOMIDE + RT |
| 210030551 | 210037420 | 1.57 | 62 | Curative (C) | 2016-02-19 | 2016-03-07 | Temozolomide + RT | 02 | N | 210025011 | TEMOZOLOMIDE + RT |
| 210030552 | 210010635 | 1.64 | 51.9 | null | 2015-11-29 | 2015-12-13 | Temozolomide + RT | null | null | 210025095 | TEMOZOLOMIDE + RT |
| 210030553 | 210020907 | 1.8 | 60.6 | Curative (C) | 2015-06-03 | 2015-07-08 | Temozolomide + RT | 02 | null | 210025161 | TEMOZOLOMIDE + RT |
| 210030554 | 210010649 | 1.19 | 63.5 | Adjuvant (A) | 2014-04-18 | 2014-05-24 | Temozolomide + RT | N | N | 210025249 | TEMOZOLOMIDE + RT |